Remove 2023 Remove Anxiety disorders Remove Depression treatment
article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray).

article thumbnail

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

The first NIMH treatment outcome study , which was published in 1989, found the drug treatment (imipramine) to be no more effective than placebo when measures were taken after three months of treatment. Within days of learning of the misreporting of cancer research at Dana Farber, that story was on page one of the Times.